| Induction of self awareness in dreams through frontal low current stimulation of gamma activity U Voss, R Holzmann, A Hobson, W Paulus, J Koppehele-Gossel, ... Nature neuroscience 17 (6), 810-812, 2014 | 428 | 2014 |
| Dopamine D2 receptor binding before and after treatment of major depression measured by [123I] IBZM SPECT A Klimke, R Larisch, A Janz, H Vosberg, HW Müller-Gärtner, W Gaebel Psychiatry Research: Neuroimaging 90 (2), 91-101, 1999 | 179 | 1999 |
| In VivoEvidence for the Involvement of Dopamine-D2Receptors in Striatum and Anterior Cingulate Gyrus in Major Depression R Larisch, A Klimke, H Vosberg, S Löffler, W Gaebel, HW Müller-Gärtner Neuroimage 5 (4), 251-260, 1997 | 138 | 1997 |
| Relapse prevention in first-episode schizophrenia—maintenance vs intermittent drug treatment with prodrome-based early intervention: results of a randomized controlled trial … W Gaebel, M Riesbeck, W Wölwer, A Klimke, M Eickhoff, M von Wilmsdorff, ... The Journal of clinical psychiatry 71 (2), 17243, 2010 | 135 | 2010 |
| Randomized double blind comparison of olanzapine vs. clozapine on subjective well‐being and clinical outcome in patients with schizophrenia D Naber, M Riedel, A Klimke, EU Vorbach, M Lambert, KU Kühn, ... Acta Psychiatrica Scandinavica 111 (2), 106-115, 2005 | 128 | 2005 |
| Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations A Cerovecki, R Musil, A Klimke, F Seemüller, E Haen, R Schennach, ... CNS drugs 27, 545-572, 2013 | 111 | 2013 |
| Left-right asymmetry of striatal dopamine D2 receptors R Larisch, W Meyer, A Klimke, F Kehren, H Vosberg, HW Muller-Gartner Nuclear medicine communications 19 (8), 781-788, 1998 | 109 | 1998 |
| Increased serum S100B in elderly, chronic schizophrenic patients: negative correlation with deficit symptoms A Schmitt, T Bertsch, U Henning, H Tost, A Klimke, FA Henn, P Falkai Schizophrenia research 80 (2-3), 305-313, 2005 | 105 | 2005 |
| Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research … W Gaebel, M Riesbeck, W Wölwer, A Klimke, M Eickhoff, ... The Journal of clinical psychiatry 68 (11), 10984, 2007 | 104 | 2007 |
| Clozapine induces oxidative stress and proapoptotic gene expression in neutrophils of schizophrenic patients K Fehsel, S Loeffler, K Krieger, U Henning, M Agelink, V Kolb-Bachofen, ... Journal of clinical psychopharmacology 25 (5), 419-426, 2005 | 93 | 2005 |
| Increased serum interleukin-1β and interleukin-6 in elderly, chronic schizophrenic patients on stable antipsychotic medication A Schmitt, T Bertsch, H Tost, A Bergmann, U Henning, A Klimke, P Falkai Neuropsychiatric disease and treatment 1 (2), 171-177, 2005 | 81 | 2005 |
| Influence of atypical neuroleptics on executive functioning in patients with schizophrenia: a randomized, double-blind comparison of olanzapine vs. clozapine S Bender, A Dittmann-Balcar, U Schall, J Wolstein, A Klimke, M Riedel, ... International journal of neuropsychopharmacology 9 (2), 135-145, 2006 | 76 | 2006 |
| Genomewide scan and fine-mapping linkage studies in four European samples with bipolar affective disorder suggest a new susceptibility locus on chromosome 1p35-p36 and provides … J Schumacher, R Kaneva, R Abou Jamra, GO Diaz, S Ohlraun, ... The American Journal of Human Genetics 77 (6), 1102-1111, 2005 | 71 | 2005 |
| Sudden death after intravenous application of lorazepam in a patient treated with clozapine. A Klimke, E Klieser The American journal of psychiatry, 1994 | 71 | 1994 |
| Hydroxychloroquine as an aerosol might markedly reduce and even prevent severe clinical symptoms after SARS-CoV-2 infection A Klimke, G Hefner, B Will, U Voss Medical hypotheses 142, 109783, 2020 | 61 | 2020 |
| Rates and predictors of remission in first-episode schizophrenia within 1 year of antipsychotic maintenance treatment. Results of a randomized controlled trial within the … W Gaebel, M Riesbeck, W Wölwer, A Klimke, M Eickhoff, M von Wilmsdorff, ... Schizophrenia research 152 (2-3), 478-486, 2014 | 58 | 2014 |
| Clozapine therapy raises serum concentrations of high sensitive C-reactive protein in schizophrenic patients S Löffler, M Löffler-Ensgraber, K Fehsel, A Klimke International clinical psychopharmacology 25 (2), 101-106, 2010 | 52 | 2010 |
| Case report: successful treatment of therapy-resistant OCD with application of transcranial alternating current stimulation (tACS) A Klimke, MA Nitsche, K Maurer, U Voss Brain Stimulation: Basic, Translational, and Clinical Research in …, 2016 | 51 | 2016 |
| Imaging dopamine D4 receptors in the living primate brain: A positron emission tomography study using the novel D1/ D4 antagonist [11C]SDZ GLC 756 C Boy, A Klimke, M Holschbach, H Herzog, H Mühlenstepen, ER Kops, ... Synapse 30 (4), 341-350, 1998 | 50 | 1998 |
| Neuropsychological impairments predict the clinical course in schizophrenia W Wölwer, J Brinkmeyer, M Riesbeck, L Freimüller, A Klimke, M Wagner, ... European archives of psychiatry and clinical neuroscience 258, 28-34, 2008 | 46 | 2008 |
